OSCAR HEALTH INC - CLASS A (OSCR) Forecast, Price Target & Analyst Ratings

NYSE:OSCR • US6877931096

Current stock price

11.47 USD
+0.62 (+5.71%)
At close:
11.6 USD
+0.13 (+1.13%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for OSCAR HEALTH INC - CLASS A (OSCR).

Forecast Snapshot

Consensus Price Target

Price Target
$16.00
+ 39.51% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
$1.16
Revenue Estimate
5.026B
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
52.94%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$16.00
Upside
+ 39.51%
From current price of $11.47 to mean target of $16.00, Based on 17 analyst forecasts
Low
$8.08
Median
$17.34
High
$24.15

Price Target Revisions

1 Month
0.00%
3 Months
4.04%

Price Target Summary

17 Wall Street analysts provided a forecast for the next 12 months for OSCR. The average price target is 16 USD. This implies a price increase of 39.51% is expected in the next year compared to the current price of 11.47.
The average price target has been revised upward by 4.04% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

OSCR Current Analyst RatingOSCR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

OSCR Historical Analyst RatingsOSCR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
52.94%
OSCR was analyzed by 17 analysts. The buy percentage consensus is at 53. So analysts seem to be rather neutral about OSCR.
In the previous month the buy percentage consensus was at a similar level.
OSCR was analyzed by 17 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-01-09UBSUpgrade Sell -> Neutral
2026-01-05BarclaysUpgrade Underweight -> Equal-Weight
2025-12-11Stephens & Co.Initiate Equal-Weight
2025-11-26Piper SandlerUpgrade Neutral -> Overweight
2025-11-13Wells FargoMaintains Underweight -> Underweight
2025-11-10BarclaysMaintains Underweight -> Underweight
2025-11-07UBSMaintains Sell -> Sell
2025-10-14Goldman SachsInitiate Neutral
2025-10-07Wells FargoMaintains Underweight -> Underweight
2025-08-14Piper SandlerMaintains Neutral -> Neutral
2025-07-25BairdDowngrade Outperform -> Neutral
2025-07-23BarclaysMaintains Underweight -> Underweight
2025-07-15UBSDowngrade Neutral -> Sell
2025-07-11Wells FargoDowngrade Equal-Weight -> Underweight
2025-07-02BarclaysInitiate Underweight
2025-06-09Piper SandlerMaintains Overweight -> Overweight
2025-03-13Wells FargoDowngrade Overweight -> Equal-Weight
2024-12-10JefferiesInitiate Underperform
2024-11-06B of A SecuritiesDowngrade Neutral -> Underperform
2024-10-07UBSInitiate Neutral
2024-09-10Piper SandlerReiterate Overweight -> Overweight
2024-08-08Piper SandlerMaintains Overweight -> Overweight
2024-07-10Piper SandlerMaintains Overweight -> Overweight
2024-06-26Piper SandlerInitiate Overweight
2024-06-12Wells FargoMaintains Overweight -> Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
$1.16
Revenue Estimate
5.026B
Revenue Q2Q
64.99%
EPS Q2Q
25.59%
Number of Analysts
13

Next Earnings Revisions

Revenue (1 Month)
-0.06%
Revenue (3 Months)
56.82%
EPS (1 Month)
-0.14%
EPS (3 Months)
54.93%

Next Earnings Summary

OSCR is expected to report earnings on 5/5/2026. The consensus EPS estimate for the next earnings is 1.16 USD and the consensus revenue estimate is 5.03B USD.
The next earnings revenue estimate has been revised upward by 56.82% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2028

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
OSCR revenue by date.OSCR revenue by date.
5.863B
47.92%		9.178B
56.54%		11.701B
27.50%		19.159B
63.73%		20.194B
5.40%		22.065B
9.27%
EBITDA
YoY % growth
OSCR ebitda by date.OSCR ebitda by date.
-204.921M
64.34%		89.41M
143.63%		-367.465M
-510.99%		380.93M
203.66%		622.7M
63.47%		828.42M
33.04%
EBIT
YoY % growth
OSCR ebit by date.OSCR ebit by date.
-235.615M
60.06%		57.265M
124.30%		-396.357M
-792.15%		254.21M
164.14%		567.58M
123.27%		645.35M
13.70%
Operating Margin
OSCR operating margin by date.OSCR operating margin by date.
-4.02%0.62%-3.39%1.33%2.81%2.92%
EPS
YoY % growth
OSCR eps by date.OSCR eps by date.
-1.20
57.89%		-0.02
98.33%		-1.74
-8,600.00%		0.57
132.83%		1.31
128.97%		1.92
47.01%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		1.16
25.59%		0.22
125.11%		-0.06
89.15%		-0.93
25.15%		1.56
35.07%		0.52
131.26%		0.15
364.37%		-0.86
7.27%		1.43
-8.17%		0.41
-20.07%		0.25
64.43%		-0.50
41.93%
Revenue
Q2Q % growth		5.026B
64.99%		4.889B
70.71%		4.729B
58.37%		4.515B
60.95%		5.087B
1.21%		5.163B
5.60%		5.123B
8.33%		4.94B
9.41%		5.374B
5.64%		5.992B
16.06%		5.982B
16.77%		5.754B
16.48%
EBITDA
Q2Q % growth		464.38M
52.83%		111.91M
151.62%		21.094M
119.49%		-267.474M
12.26%		617.66M
33.01%		239.84M
114.32%		101.59M
381.61%		-232.829M
12.95%		711.38M
15.17%		301.35M
25.65%		164.46M
61.89%		-216.138M
7.17%
EBIT
Q2Q % growth		442.6M
48.96%		86.843M
137.68%		-2.381M
98.16%		-287.881M
13.74%		658.07M
48.68%		233.2M
168.53%		88.672M
3,823.76%		-308.797M
-7.27%		701.84M
6.65%		291.81M
25.13%		154.93M
74.72%		-225.675M
26.92%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

OSCR Yearly Revenue VS EstimatesOSCR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B
OSCR Yearly EPS VS EstimatesOSCR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 -2 -3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
45.89%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
21.64%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
69.34%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

OSCAR HEALTH INC - CLASS A / OSCR Forecast FAQ

What is the price target for OSCR stock?

17 analysts have analysed OSCR and the average price target is 16 USD. This implies a price increase of 39.51% is expected in the next year compared to the current price of 11.47.

What is the next earnings date for OSCR stock?

OSCAR HEALTH INC - CLASS A (OSCR) will report earnings on 2026-05-05.

What are the consensus estimates for OSCR stock next earnings?

The consensus EPS estimate for the next earnings of OSCAR HEALTH INC - CLASS A (OSCR) is 1.16 USD and the consensus revenue estimate is 5.03B USD.

How many analysts cover OSCAR HEALTH INC - CLASS A (OSCR) stock?

The number of analysts covering OSCAR HEALTH INC - CLASS A (OSCR) is 17.